-
Stem cells may finally offer a cure for Type 1 diabetes
There are 537 million people around the world living with diabetes. And that number is growing. When people have Type 1 diabetes, the immune system attacks and destroys the beta cells in the pancreas that make insulin. These cells regulate glucose levels in the blood which the body needs for energy.…
-
Insulin-Producing Cells May Last Longer in People With Type 1 Diabetes
Key Takeaways Researchers have found that people with Type 1 diabetes may retain beta cells for much longer than previously thought. Healthcare experts say that the study’s findings do not necessarily mean that insulin treatment and beta cell replacement therapy are no longer needed. Researchers are seeking to develop a…
-
Could an ‘invisible’ cell transplant treat diabetes?
Type 1 diabetes used to be a death sentence. After a diagnosis, patients were put on a starvation diet. The lucky ones would have a year or two to live. But, thanks to the discovery of insulin in the early 1920s, this is no longer the case. We need insulin…
-
Bioprinted therapeutic offers novel solution for treating Type 1 Diabetes
VANCOUVER, BC, Sept. 22, 2020 /CNW/ – Type 1 Diabetes (T1D), once known as insulin dependent diabetes, is a chronic condition that causes pancreatic cells to produce little or no insulin. Insulin plays an important role in regulating blood sugar, or glucose, so T1D patients cannot naturally regulate their blood…
-
Major advancement in islet cell transplantation for treating Type-1 diabetes
A cure for Type-1 diabetes has come closer with the development of a new method for keeping transplanted insulin-producing cells alive and functional in recipients for long periods even when transplanted underneath the skin. A team led by researchers at the Perelman School of Medicine reports the new method, and…
-
Researchers Develop Potential Breakthrough in Type 1 Diabetes Treatment
Researchers from the Salk Institute took a major step forward in developing a new insulin-producing pancreatic cell cluster as a potential treatment for type 1 diabetes patients. The pancreatic cell clusters were developed with stem cell technology and were able to avoid detection by the immune system. That means the…
-
Biological ‘atlas’ shows dual personality for immune cells that cause Type 1 diabetes
Immunologists at St. Jude Children’s Research Hospital have created a database that identifies gene-regulatory mechanisms in immune cells that facilitate Type 1 diabetes. The findings were published today in Nature Immunology. Type 1 diabetes is an autoimmune disease in which the immune system attacks the body’s own cells. In Type…
-
Full interview: Genprex’s newly licensed type 1 diabetes gene therapy’s potential explained by scientist
Dr George Gittes, Professor of Surgery at the Children’s Hospital of Pittsburgh explains how and why he began working on the gene therapy licensed by Genprex (NASDAQ:GNPX). Dr Gittes says the therapy, currently undergoing pre-clinical studies, has shown data where it caused pancreatic cells to turn into insulin-producing cells. Watch…
-
Breakthrough Research Cures Diabetes Type 1 Using Stem Cells
New research, which was led by the assistant professor of medicine and biomedical engineering at Washington University School of Medicine in St. Louis, Jeffrey R. Millman, has recently shown the potential of stem cells in the treatment of type 1 diabetes. More specifically, the researchers looked at how stem cells…
-
Do Pancreatic Cells Write Their Own Autoimmune Ending?
Do the insulin-producing beta cells in the pancreas unwittingly produce a signal that aids their own demise in Type 1 diabetes? That appears to be the case, according to lipid signaling research co-led by Sasanka Ramanadham, Ph.D., professor of cell, developmental and integrative biology at the University of Alabama at…
